The DOI matches its Crossref record; 25 of the 25 references it cites were found in a registry or an index.
Distribution and Expression of Picalm in Alzheimer Disease
Open accessAbstract
PICALM, the gene encoding phosphatidylinositol-binding clathrin assembly (picalm) protein, was recently shown to be associated with risk of Alzheimer disease (AD). Picalm is a key component of clathrin-mediated endocytosis. It recruits clathrin and adaptor protein 2 (AP-2) to the plasma membrane and, along with, AP-2 recognizes target proteins. The attached clathrin triskelions cause membrane deformation around the target proteins enclosing them within clathrin-coated vesicles to be processed in lysosomes or endosomes. We examined the distribution of picalm in control and AD brain tissue and measured levels of picalm messenger RNA (mRNA) by real-time polymerase chain reaction. Immunolabeling of brain tissue showed that picalm is predominately present in endothelial cells. This was further supported by the demonstration of picalm in human cerebral microvascular cells grown in culture. Picalm mRNA was elevated in relation to glyceraldehyde-3-phosphate dehydrogenase but not factor VIII-related antigen or CD31 mRNA in the frontal cortex in AD. No change was seen in the temporal cortex or thalamus. The transport of Aβ across vessel walls and into the bloodstream is a major pathway of Aβ removal from the brain and picalm is ideally situated within endothelial cells to participate in this process. Further research is needed to determine whether PICALM expression is influenced by Aβ levels and whether it affects Aβ uptake and transport by endothelial cells.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Although our study indicates a reduced PICALM expression in LOAD-risk-allele iMGs, PICALM expression in patients with AD may also be influenced by cell type, MG state and disease stage31,56.”
From PICALM Alzheimer’s risk allele causes aberrant lipid droplets in microglia (2025) · cites this paper as [56]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Harold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
Self-citationGenome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234
HYMAN, B. T., & TROJANOWSKI, J. Q. (1997) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199710000-00002 · Cited by 1,542
Consensus Recommendations for the Postmortem Diagnosis of Alzheimer’s Disease
(1997) · Neurobiology of Aging · doi:10.1016/s0197-4580(97)00057-2 · Cited by 981
Evidence that production and release of amyloid beta-protein involves the endocytic pathway
Koo, E. H., & Squazzo, S. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32449-3 · Cited by 829
Chen, W. J., Goldstein, J. L., & Brown, M. S. (1990) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)39742-x · Cited by 731
Ford, M. G. J., Pearse, B. M. F., Higgins, M. K., Vallis, Y., Owen, D. J., Gibson, A., Hopkins, C. R., Evans, P. R., & McMahon, H. T. (2001) · Science · doi:10.1126/science.291.5506.1051 · Cited by 659
Endocytosis Is Required for Synaptic Activity-Dependent Release of Amyloid-β In Vivo
Cirrito, J. R., Kang, J.-E., Lee, J., Stewart, F. R., Verges, D. K., Silverio, L. M., Bu, G., Mennerick, S., & Holtzman, D. M. (2008) · Neuron · doi:10.1016/j.neuron.2008.02.003 · Cited by 635
The Structural Era of Endocytosis
Marsh, M., & McMahon, H. T. (1999) · Science · doi:10.1126/science.285.5425.215 · Cited by 560
Cited by
Sorted by citations
Epidemiology of Alzheimer disease
Reitz, C., Brayne, C., & Mayeux, R. (2011) · Nature Reviews Neurology · doi:10.1038/nrneurol.2011.2 · Cited by 1,675
Alzheimer’s Disease Risk Genes and Mechanisms of Disease Pathogenesis
Karch, C. M., & Goate, A. M. (2015) · Biological Psychiatry · doi:10.1016/j.biopsych.2014.05.006 · Cited by 1,357
Epidemiology of Alzheimer DiseasePreprint
Mayeux, R. P., & Stern, Y. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006239 · Cited by 1,127
The Genetics of Alzheimer Disease: Back to the Future
Bertram, L., Lill, C. M., & Tanzi, R. E. (2010) · Neuron · doi:10.1016/j.neuron.2010.10.013 · Cited by 834
The Genetics of Alzheimer's Disease
Bertram, L., & Tanzi, R. E. (2012) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-385883-2.00008-4 · Cited by 794
Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance
Zhao, Z., Sagare, A. P., Ma, Q., Halliday, M. R., Kong, P., Kisler, K., Winkler, E. A., Ramanathan, A., Kanekiyo, T., Bu, G., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4025 · Cited by 410
Genes associated with Alzheimer's disease: an overview and current status
Giri, M., Lü, Y., & Zhang, M. (2016) · Clinical Interventions in Aging · doi:10.2147/cia.s105769 · Cited by 311
Clearance of cerebral Aβ in Alzheimer’s disease: reassessing the role of microglia and monocytes
Zuroff, L. R., Daley, D. A., Black, K. L., & Koronyo‐Hamaoui, M. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-017-2463-7 · Cited by 292
Endo-lysosomal dysregulations and late-onset Alzheimer’s disease: impact of genetic risk factors
Van Acker, Z. P., Bretou, M., & Annaert, W. (2019) · Molecular Neurodegeneration · doi:10.1186/s13024-019-0323-7 · Cited by 222
Ramanathan, A., Nelson, A. R., Sagare, A. P., & Zlokovic, B. V. (2015) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2015.00136 · Cited by 205
The Molecular Basis for the Endocytosis of Small R-SNAREs by the Clathrin Adaptor CALM
Miller, S. E., Sahlender, D. A., Graham, S. C., Höning, S., Robinson, M. S., Peden, A. A., & Owen, D. J. (2011) · Cell · doi:10.1016/j.cell.2011.10.038 · Cited by 192
Moulton, M. J., Barish, S., Ralhan, I., Chang, J., Goodman, L. D., Harland, J. G., Marcogliese, P. C., Johansson, J. O., Ioannou, M. S., & Bellen, H. J. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2112095118 · Cited by 180
Genetic analysis of quantitative phenotypes in AD and MCI: imaging, cognition and biomarkers
Initiative, A. D. N., Shen, L., Thompson, P. M., Potkin, S. G., Bertram, L., Farrer, L. A., Foroud, T., Green, R. C., Hu, X., Huentelman, M. J., et al. (2013) · Brain Imaging and Behavior · doi:10.1007/s11682-013-9262-z · Cited by 176
Xiao, Q., Gil, S.-C., Yan, P., Wang, Y., Han, S., Gonzales, E., Perez, R., Cirrito, J. R., & Lee, J.-M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.338376 · Cited by 166
Label-Free Quantitative LC–MS Proteomics of Alzheimer’s Disease and Normally Aged Human Brains
Andreev, V. P., Petyuk, V., Brewer, H. M., Karpievitch, Y. V., Xie, F., Clarke, J., Camp, D., Smith, R. D., Lieberman, A. P., Albin, R. L., et al. (2012) · Journal of Proteome Research · doi:10.1021/pr3001546 · Cited by 142
Ando, K., Brion, J.-P., Stygelbout, V., Suain, V., Authelet, M., Dedecker, R., Chanut, A., Lacor, P., Lavaur, J., Sazdovitch, V., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1111-z · Cited by 136
Protective genes and pathways in Alzheimer’s disease: moving towards precision interventions
Seto, M., Weiner, R. L., Dumitrescu, L., & Hohman, T. J. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00452-5 · Cited by 135
The genetic landscape of Alzheimer disease
Carmona, S., Hardy, J., & Guerreiro, R. J. (2018) · Handbook of clinical neurology · doi:10.1016/b978-0-444-64076-5.00026-0 · Cited by 140
Genetics of Alzheimer's disease: new evidences for an old hypothesis?
Lambert, J., & Amouyel, P. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2011.02.002 · Cited by 141
The Role of PICALM in Alzheimer’s Disease
Xu, W., Tan, L., & Yu, J. (2014) · Molecular Neurobiology · doi:10.1007/s12035-014-8878-3 · Cited by 124
Lysosomal Network Proteins as Potential Novel CSF Biomarkers for Alzheimer’s Disease
Armstrong, A., Mattsson, N., Appelqvist, H., Janefjord, C., Sandin, L., Agholme, L., Olsson, B., Svensson, S., Blennow, K., Zetterberg, H., et al. (2013) · NeuroMolecular Medicine · doi:10.1007/s12017-013-8269-3 · Cited by 113
PICALM and Alzheimer’s Disease: An Update and Perspectives
Ando, K., Nagaraj, S., Küçükali, F., de Fisenne, M.-A., Kosa, A.-C., Doeraene, E., Lopez Gutierrez, L., Brion, J.-P., & Leroy, K. (2022) · Cells · doi:10.3390/cells11243994 · Cited by 104
Cossec, J., Lavaur, J., Berman, D. E., Rivals, I., Hoischen, A., Stora, S., Ripoll, C., Mircher, C., Grattau, Y., Olivo‐Marín, J., et al. (2012) · Human Molecular Genetics · doi:10.1093/hmg/dds142 · Cited by 106
Slow Excitotoxicity in Alzheimer's Disease
Ong, W.-Y., Tanaka, K., Dawe, G. S., Ittner, L. M., & Farooqui, A. A. (2013) · Journal of Alzheimer s Disease · doi:10.3233/jad-121990 · Cited by 106
Stefanova, N. A., Kozhevnikova, O. S., Vitovtov, A. O., Maksimova, K. Y., Logvinov, S. V., Rudnitskaya, E. A., Korbolina, E. E., Muraleva, N. A., & Kolosova, N. G. (2014) · Cell Cycle · doi:10.4161/cc.28255 · Cited by 97
An overview of the genes and biomarkers in Alzheimer’s disease
Krishnamurthy, H. K., Jayaraman, V., Krishna, K., Wang, T., Bei, K., Changalath, C., & Rajasekaran, J. J. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102599 · Cited by 89
Genetics of PICALM Expression and Alzheimer's Disease
Parikh, I. J., Fardo, D. W., & Estus, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0091242 · Cited by 73
Ando, K., Tomimura, K., Sazdovitch, V., Suain, V., Yilmaz, Z., Authelet, M., Ndjim, M., Vergara, C., Belkouch, M., Potier, M., et al. (2016) · Neurobiology of Disease · doi:10.1016/j.nbd.2016.05.017 · Cited by 71
Dysregulation of Rab5‐mediated endocytic pathways in Alzheimer's disease
Xu, W. L., Fang, F., Ding, J., & Wu, C. (2018) · Traffic · doi:10.1111/tra.12547 · Cited by 72
Sweet, R. A., Seltman, H. J., Emanuel, J. E., López, O. L., Becker, J. T., Bis, J. C., Weamer, E. A., DeMichele‐Sweet, M. A. A., & Kuller, L. H. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.11121815 · Cited by 68
Alzheimer’s disease and the autophagic-lysosomal system
Chung, K. M., Hernández, N., Sproul, A. A., & Yu, W. H. (2019) · Neuroscience Letters · doi:10.1016/j.neulet.2018.05.017 · Cited by 63
Morgen, K., Ramı́rez, A., Frölich, L., Tost, H., Plichta, M. M., Kölsch, H., Rakebrandt, F., Rienhoff, O., Jessen, F., Peters, O., et al. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2013.11.001 · Cited by 59
Genetics and Underlying Pathology of Dementia
Ferencz, B., & Gerritsen, L. (2015) · Neuropsychology Review · doi:10.1007/s11065-014-9276-3 · Cited by 58
Thomas, R. S., Henson, A., Gerrish, A., Jones, L., Williams, J., & Kidd, E. J. (2016) · BMC Neuroscience · doi:10.1186/s12868-016-0288-1 · Cited by 55
Self-citationDong, H. K., Gim, J., Yeo, S. H., & Kim, H. (2016) · Gene · doi:10.1016/j.gene.2016.10.022 · Cited by 57
PICALM Alzheimer’s risk allele causes aberrant lipid droplets in microglia
Kozlova, A., Zhang, S., Sudwarts, A., Zhang, H., Smirnou, S., Byeon, S. K., Thapa, C., Sun, X., Stephenson, K., Zhao, X., et al. (2025) · Nature · doi:10.1038/s41586-025-09486-x · Cited by 53
“Although our study indicates a reduced PICALM expression in LOAD-risk-allele iMGs, PICALM expression in patients with AD may also be influenced by cell type, MG state and disease stage 31,56 .”
Ikonomović, M. D., Mi, Z., & Abrahamson, E. E. (2016) · Ageing Research Reviews · doi:10.1016/j.arr.2016.11.003 · Cited by 53
van Rooij, J., Meeter, L. H. H., Melhem, S., Nijholt, D. A. T., Wong, T. H., Rozemüller, A. J. M., Uitterlinden, A. G., van Meurs, J. B. J., & Swieten, J. C. V. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.10.023 · Cited by 47
Alzheimer's disease genes and autophagy
Yoon, S.-Y., & Kim, D.-H. (2016) · Brain Research · doi:10.1016/j.brainres.2016.03.018 · Cited by 42
Explorative and targeted neuroproteomics in Alzheimer's disease
Brinkmalm, A., Portelius, E., Öhrfelt, A., Brinkmalm, G., Andréasson, U., Gobom, J., Blennow, K., & Zetterberg, H. (2015) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2015.01.009 · Cited by 45
Ahmad, S., Bannister, C. A., van der Lee, S. J., Vojinović, D., Adams, H. H. H., Ramírez, A., Escott‐Price, V., Sims, R., Baker, E. A., Williams, J. H., et al. (2018) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2018.01.005 · Cited by 46
Self-citationState of Play in Alzheimer’s Disease Genetics
Zhu, J.-B., Tan, C., Tan, L., & Yu, J. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170062 · Cited by 44
McIntee, F. L., Giannoni, P., Blais, S. P., Sommer, G., Neubert, T. A., Rostagno, A. A., & Ghiso, J. A. (2016) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2016.00223 · Cited by 42
Protein Oxidation in Aging and Alzheimer’s Disease Brain
Rukhsana Sultana, A., & Butterfield, D. A. (2024) · Antioxidants · doi:10.3390/antiox13050574 · Cited by 43
Thomas, R. S., Lelos, M. J., Good, M. A., & Kidd, E. J. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.10.131 · Cited by 41
Dubey, H., Gulati, K., & Ray, A. (2018) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0049 · Cited by 36
Kozhevnikova, O. S., Korbolina, E. E., Stefanova, N. A., Muraleva, N. A., Orlov, Y. L., & Kolosova, N. G. (2013) · Biogerontology · doi:10.1007/s10522-013-9439-2 · Cited by 35
Epistatic Genetic Effects among Alzheimer’s Candidate Genes
Hohman, T. J., Koran, M. E. I., Thornton‐Wells, T. A., & Initiative, A. D. N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0080839 · Cited by 35
Alzheimer's disease genetics: lessons to improve disease modelling
Guerreiro, R. J., & Hardy, J. (2011) · Biochemical Society Transactions · doi:10.1042/bst0390910 · Cited by 33
Endocytosis and Alzheimer’s disease
Zadka, Ł., Sochocka, M., Hachiya, N., Chojdak-Łukasiewicz, J., Dzięgiel, P., Piasecki, E., & Leszek, J. (2023) · GeroScience · doi:10.1007/s11357-023-00923-1 · Cited by 33
Gadhave, K., Gehi, B. R., Kumar, P., Xue, B., Uversky, V. N., & Giri, R. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03414-9 · Cited by 35
The MUC6/AP2A2 Locus and Its Relevance to Alzheimer’s Disease: A Review
Nelson, P. T., Fardo, D. W., & Katsumata, Y. (2020) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nlaa024 · Cited by 28
Kisler, K., Sagare, A. P., Lazić, D., Bazzi, S. A., Lawson, E. J., Hsu, C.-J., Wang, Y., Ramanathan, A., Nelson, A. R., Zhao, Z., et al. (2023) · Molecular Neurodegeneration · doi:10.1186/s13024-023-00597-5 · Cited by 29
Zafar, S., Younas, N., Correia, S., Shafiq, M., Tahir, W., Schmitz, M., Ferrer, I., Andréoletti, O., & Zerr, I. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9694-8 · Cited by 28
Alzheimer’s Disease Genetics: Review of Novel Loci Associated with Disease
Tábuas‐Pereira, M., Santana, I. J., Guerreiro, R. J., & Brás, J. (2020) · Current Genetic Medicine Reports · doi:10.1007/s40142-020-00182-y · Cited by 26
Unraveling the genes implicated in Alzheimer's disease
Giri, M., Shah, A., Upreti, B., & Rai, J. C. (2017) · Biomedical Reports · doi:10.3892/br.2017.927 · Cited by 25
Jaye, S., Sandau, U. S., & Saugstad, J. A. (2024) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2024.1378576 · Cited by 26
New Genes and New Insights from Old Genes
Ringman, J. M., & Coppola, G. (2013) · CONTINUUM Lifelong Learning in Neurology · doi:10.1212/01.con.0000429179.21977.a1 · Cited by 27
The Biochemical Properties and Functions of CALM and AP180 in Clathrin Mediated Endocytosis
Moshkanbaryans, L., Chan, L.-S., & Graham, M. E. (2014) · Membranes · doi:10.3390/membranes4030388 · Cited by 26
Exosomal MicroRNA-155 Inhibits Enterovirus A71 Infection by Targeting PICALM
Wu, J., Gu, J., Shen, L., Fang, D., Zou, X., Cao, Y., Wang, S., & Mao, L. (2019) · International Journal of Biological Sciences · doi:10.7150/ijbs.36388 · Cited by 23
Schnetz‐Boutaud, N. C., Hoffman, J., Coe, J., Murdock, D. G., Pericak‐Vance, M. A., & Haines, J. L. (2012) · Annals of Human Genetics · doi:10.1111/j.1469-1809.2012.00727.x · Cited by 23
Zhou, Q., Sheng, C., Zheng, S., Wang, Z., Guan, P., Zhu, Z., Huang, X., Zhou, C., & Li, G. (2022) · Nucleic Acids Research · doi:10.1093/nar/gkac893 · Cited by 22
Пономарева, Н. В., Андреева, Т. В., Protasova, M., Shagam, L. I., Malina, D. D., Goltsov, A. Y., Fokin, V. F., Illarioshkin, S. N., & Rogaev, E. I. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.12.010 · Cited by 21
The blood–brain barrier as a treatment target for neurodegenerative disorders
Rust, R., Sagare, A. P., Zhang, M., Zloković, B. V., & Kisler, K. (2025) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2025.2480654 · Cited by 21
Lessons from genome‐wide association studies findings in Alzheimer's disease
Moraes, C. F., Lins, T. C. D. L., CARMARGOS, E. F., Naves, J. O. S., Pereira, R. W., & Nóbrega, O. D. T. (2011) · Psychogeriatrics · doi:10.1111/j.1479-8301.2011.00378.x · Cited by 19
Exploring the potential role of rab5 protein in endo-lysosomal impairment in Alzheimer’s disease
Behl, T., Kaur, D., Sehgal, A., Singh, S., Makeen, H. A., Albratty, M., Abdellatif, A. A. H., Dachani, S. R., & BUNGAU, S. G. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.112773 · Cited by 20
Merthan, L., Haller, A., Thal, D. R., von Einem, B., & Arnim, C. A. F. V. (2019) · Biochemical Journal · doi:10.1042/bcj20180840 · Cited by 18
Zhuang, L., Liu, X., Shi, Y., Liu, X., & Luo, B. (2019) · Frontiers in Neurology · doi:10.3389/fneur.2019.00494 · Cited by 17
Modulation of PICALM Levels Perturbs Cellular Cholesterol Homeostasis
Mercer, J. L., Argus, J. P., Crabtree, D. M., Keenan, M. M., Wilks, M. Q., Chi, J.-T. A., Bensinger, S. J., Lavau, C. P., & Wechsler, D. S. (2015) · PLOS ONE · doi:10.1371/journal.pone.0129776 · Cited by 17
An intronic PICALM polymorphism, rs588076, is associated with allelic expression of a PICALMisoform
Parikh, I. J., Medway, C., Younkin, S. G., Fardo, D. W., & Estus, S. (2014) · Molecular Neurodegeneration · doi:10.1186/1750-1326-9-32 · Cited by 17
Xu, W., Initiative, A. D. N., Tan, C., Cao, X., & Tan, L. (2020) · Aging · doi:10.18632/aging.103814 · Cited by 16
Liu, Z., Dai, X., Zhang, J., Li, X., Chen, Y., Ma, C., Chen, K., Peng, D., & Zhang, Z. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0358-5 · Cited by 13
CRISPR/Cas9 Gene Editing: A Novel Approach Towards Alzheimer's Disease Treatment
Tripathi, S., Sharma, Y., Rane, R. A., & Kumar, D. (2024) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/0118715273283786240408034408 · Cited by 11
Approaches for Increasing Cerebral Efflux of Amyloid-β in Experimental Systems
Loeffler, D. A. (2024) · Journal of Alzheimer s Disease · doi:10.3233/jad-240212 · Cited by 12
Ma, S., Li, Q., Yang, X., Liang, G., Zhang, L., Li, Q., Xiong, F., Peng, S., Ma, Y., Huang, X., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0145856 · Cited by 10
Takatori, S., & Tomita, T. (2018) · Advances in experimental medicine and biology · doi:10.1007/5584_2018_218 · Cited by 10
Wu, Z., Yang, Y., Song, Z., Ma, M., Feng, M., Liu, Y., Xing, H., Chang, Y., & Dai, H. (2022) · Brain Sciences · doi:10.3390/brainsci12121681 · Cited by 8
Patel, S., Park, M. T. M., Chakravarty, M. M., & Knight, J. (2016) · Frontiers in Neuroinformatics · doi:10.3389/fninf.2016.00014 · Cited by 11
Velez, J. I., Samper, L. A., Arcos-Holzinger, M., Espinosa, L. G., Isaza-Ruget, M. A., Lopera, F. J., & Arcos‐Burgos, M. (2021) · Diagnostics · doi:10.3390/diagnostics11050887 · Cited by 9
The Genetic Basis of Alzheimer's Disease
Hooli, B. V., & Tanzi, R. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-800105-9.00034-2 · Cited by 9
Ma, S. L., & LAM, L. C. W. (2011) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2011.9.2.54 · Cited by 8
Giovani, P. A., Salmon, C. R., Martins, L., Leme, A. F. P., Puppin‐Rontani, R. M., Mofatto, L. S., Nociti, F. H., & Kantovitz, K. R. (2018) · Journal of Periodontology · doi:10.1002/jper.18-0217 · Cited by 8
Network Dynamics‐based Subtyping of Alzheimer's Disease With Microglial Genetic Risk Factors
Choi, J. H., Lee, J., Kang, U., Chang, H., & Cho, K.-H. (2024) · Alzheimer's Research & Therapy · doi:10.1186/s13195-024-01583-9 · Cited by 7
Large‐scale sequencing studies expand the known genetic architecture of Alzheimer's disease
Xue, D., Bush, W. S., Renton, A. E., Marcora, E. M., Bis, J. C., Kunkle, B. W., The Alzheimer's Disease Sequencing Project, Boerwinkle, E., DeStefano, A. L., Farrer, L. A., et al. (2021) · Alzheimer s & Dementia Diagnosis Assessment & Disease Monitoring · doi:10.1002/dad2.12255 · Cited by 8
Regueira, P., Silva, A. R., Cardoso, A. L., Cardoso, A. M., Baldeiras, I., Santana, I. J., & Cerejeira, J. (2022) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2022.100503 · Cited by 6
The Genetic Basis of Alzheimer’s Disease
Hooli, B. V., & Tanzi, R. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802173-6.00002-2 · Cited by 6
The Role of Genetics in Alzheimer's Disease and Parkinson's Disease
Porter, T., Gozt, A., Mastaglia, F. L., & Laws, S. M. (2019) · Wiley eBooks · doi:10.1002/9781119356752.ch15 · Cited by 6
Amber, S., & Zahid, S. (2024) · Frontiers in Genetics · doi:10.3389/fgene.2024.1271404 · Cited by 5
Ji, W., Xu, L., Zhou, H., Wang, S., & Fang, Y. (2015) · PubMed · Cited by 5
Recent Advances and Future Directions in Alzheimer’s Disease Genetic Research
Stancheva, M., Toncheva, D. I., & Karachanak-Yankova, S. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167819 · Cited by 4
Zhu, Y., Zang, F., Liu, X., Fan, D., Zhang, Q., Ren, Q., Xie, C., & Initiative, A. D. N. (2020) · Brain Imaging and Behavior · doi:10.1007/s11682-020-00316-4 · Cited by 4
Mass spectrometry quantification of PICALM and AP180 in human frontal cortex and neural retina
Chen, J., Pikuleva, I. A., & Turko, I. V. (2013) · Analytical Biochemistry · doi:10.1016/j.ab.2013.08.005 · Cited by 3
Suche nach Risikogenen bei der Alzheimer-Erkrankung
Karaca, I., Wagner, H., & Ramı́rez, A. (2017) · Der Nervenarzt · doi:10.1007/s00115-017-0354-7 · Cited by 3
Barić, N. (2021) · Rad Hrvatske akademije znanosti i umjetnosti Medicinske znanosti · doi:10.21857/yk3jwhxlq9 · Cited by 3
Feleke, R., Jogaudaite, S., Velentza‐Almpani, E., Yeung-Yeung, L., Clode, D., Ko, J. H., Shin, B., Matthews, S., Otero‐Jimenez, M., Wojewska, M. J., et al. (2025) · Acta Neuropathologica · doi:10.1007/s00401-025-02869-4 · Cited by 4
CellSP enables module discovery and visualization for subcellular spatial transcriptomics data
Aggarwal, B., & Sinha, S. (2025) · Communications Biology · doi:10.1038/s42003-025-08891-2 · Cited by 1
Shafi, V., & Siddiqui, I. (2024) · Research Square · doi:10.21203/rs.3.rs-4408464/v1 · Cited by 1
Simmons, C. R. (2011) · UKnowledge (University of Kentucky)
Further insights into Alzheimer's disease
Sims, R., Gerrish, A., & Williams, J. H. (2012) · Quality in Ageing and Older Adults · doi:10.1108/14717791211264043
Self-citation
Metadata
- Authors
- Baig, S., Joseph, S. A., Tayler, H., Abraham, R., Owen, M. J., Williams, J., Kehoe, P. G., & Love, S.
- Affiliations
- Frenchay Hospital (GB)
- Corresponding author
- Baig, Shabnam
- Venue
- Journal of Neuropathology & Experimental Neurology
- Publisher
- Oxford University Press (OUP)
- Published
- 2010-10
- Volume
- 69
- Issue
- 10
- Pages
- 1071-1077
- ISSN
- 0022-3069 (ISSN-L)
- 1554-6578
- PMC
- PMC3017341
- OpenAlex
- W2010846728
- Cited by
- 115
- References
- 25
- Citations by year
- 2026: 2 · 2025: 6 · 2024: 9 · 2023: 3 · 2022: 5 · 2021: 5 · 2020: 5 · 2019: 6 · 2018: 8 · 2017: 5 · 2016: 13 · 2015: 8 · 2014: 9 · 2013: 11 · 2012: 9
- FWCI
- 6.72
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuropathology & Experimental Neurology (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- Explore Bristol Research (submittedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- Funders
- Wellcome Trust
- Alzheimer's Society
- Alzheimer's Research Trust
- Medical Research Council (G0801418, G0300429)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Life Sciences › Neuroscience › Neurology › Barrier Structure and Function Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Cellular transport and secretion
- Keywords
- PICALM, Alzheimer's disease, clathrin-mediated endocytosis, endothelial cells, cerebral microvasculature, amyloid-beta transport, gene expression, mRNA distribution, brain tissue
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Brain, Factor VIII, Female, Gene Expression Regulation, Humans, Male, RNA, Messenger, Amyloid beta-Peptides, Statistics, Nonparametric, Platelet Endothelial Cell Adhesion Molecule-1, Monomeric Clathrin Assembly Proteins, Endothelial Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
